CTX-M extended-spectrum beta-lactamases, Washington State.
Kim
Seonghan
S
Hu
Jinxin
J
Gautom
Romesh
R
Kim
Junyoung
J
Lee
Bokkwon
B
Boyle
David S
DS
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002439:Cefotaxime / Q000494:pharmacology; D002442:Ceftazidime / Q000494:pharmacology; D003227:Conjugation, Genetic; D024881:Drug Resistance, Bacterial; D004405:Dysentery, Bacillary / Q000453:epidemiology*; D005798:Genes, Bacterial / Q000235:genetics; D006801:Humans; D008826:Microbial Sensitivity Tests; D012307:Risk Factors; D012475:Salmonella / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D012480:Salmonella Infections / Q000453:epidemiology*; D012760:Shigella / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D014195:Travel; D014861:Washington / Q000453:epidemiology; D001618:beta-Lactamases / Q000235:genetics / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D002442:Ceftazidime; D001618:beta-Lactamases; D002439:Cefotaxime